Original Research

ARNTL2 is a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Triple-Negative Breast Cancer

Wang X, Li Y, Fu J, Zhou K, Wang T

Pharmacogenomics and Personalized Medicine 2021, 14:1425-1440

Published Date: 10 November 2021